Yup, it's why it would be great to partner out DurAVR so we can pursue side projects such as Mitral V2V, CABG, dura and hernias.
I find it interesting they are looking beyond Adapt with this silk based polymer. And the great thing is this material is already in humans so less risk re adverse immunogenic reactions, etc.
Next Gen DurAVR, page-7
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.75 |
Change
-0.230(1.21%) |
Mkt cap ! $360.4M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.52 | $179.2K | 9.566K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 109 | $18.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.75 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$18.52 |
Change
-0.230 ( 2.01 %) |
||||
| Open | High | Low | Volume | ||
| $18.52 | $18.52 | $18.52 | 14 | ||
| Last updated 10.49am 30/05/2024 ? | |||||
| AVR (ASX) Chart |